There is a license error on this site:
License has expired
The Web site remains functional, but this message will be displayed until the license error has been corrected.

To correct this error:If you do not have a license file, please request one from EPiServer License Center.
EPF's reaction to the draft reports on the revision of EU pharmaceutical legislation
European Patients Forum, logo.

EPF's reaction to the draft reports on the revision of EU pharmaceutical legislation

Read EPF's reaction to the draft reports on the revision of the EU pharmaceutical legislation.

The European Patients’ Forum (EPF) welcomes the publication of the draft negotiating positions, bringing the legislative process one step closer to the adoption of the revision of the EU pharmaceutical legislation. The patient community has been waiting a long time for this crucial revision, which will have an impact on their access to safe, effective and high-quality medicines, as well as on their involvement in the lifecycle of medicines.

Read our reaction here.